PRPH · CIK 0000868278 · FY2025 live · 2025-12-31
ProPhase Labs, Inc.
View as
Model
Classic Z
FY2025
−3.60
Zone
Distress
Prior
—
Market DD
—
1y PD
—
−3.60
Z″ −11.41
Score −3.60 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
−0.831.2 × = −1.00X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−1.221.4 × = −1.71X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−0.303.3 × = −0.99X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
0.060.6 × = 0.04X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.071 × = 0.07
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings.
Meridian Rank
18
0–100 · Classic Z family
Book standing
21
Year change
—
Market PD
—
O-score
10
Events on this name
Same published rows as Today.
No published events on this print.
Overview
rule-v1
ProPhase Labs, Inc. is on classic Z at −3.60 (distress) for FY2025, from an SEC 10-K. Retained earnings / assets is the line that sets the print; working capital / assets is the runner-up. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers. Buybacks can send retained earnings negative at otherwise healthy issuers. X4 is book equity.
Book screen Distress; market PD —. Market PD has not been priced on this name.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 37th percentile in Healthcare.
- TCRXDistressTScan Therapeutics, Inc.−3.58
- MYODistressMYOMO, INC.−3.62
- RYTMDistressRHYTHM PHARMACEUTICALS, INC.−3.57
- XLODistressXilio Therapeutics, Inc.−3.54
- VTVTDistressvTv Therapeutics Inc.−3.66
- RGNXDistressREGENXBIO Inc.−3.67
- ABEODistressABEONA THERAPEUTICS INC.−3.51
- AUTLDistressAutolus Therapeutics plc−3.68
KPI widgets
Current assets
$3M
Total assets
$60M
Current liabilities
$53M
Total liabilities
$56M
Working capital
−$50M
Retained earnings
−$73M
EBIT
−$18M
Total sales
$4M
Book equity
$4M
Accession 0000868278-26-000005. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as is a display overlay. X4 is book equity. Pulled 13 Sept 2026.